A new study out of Oxford University suggests COVID-19 patients could be saved with the help of dexamethasone, an inexpensive and widely used steroid. If the findings bear out, it would be the first drug known to reduce deaths of severely ill COVID-19 patients. Briana Vannozzi asked Rutgers University professor of medicine and infectious diseases Dr. Martin Blaser if it’s the breakthrough we’ve been waiting for. To watch the interview.
Recent Posts
- NJACTS Community Engagement Core Available Services
- Professor’s Research into Human Genetics Points to New Ways of Treating a Painful Gastrointestinal Disease.
- Modernizing Health Records for the Most Vulnerable.
- For Rutgers Health’s First Chancellor, Mentoring Was the Mission.
- Inspired by a Family’s Struggle, a Scientist Helps Uncover Defense Against Alzheimer’s Disease.
Categories
- Community (2,419)
- Covid (994)
- CTO Events (6)
- News (3,061)
- Pilots (21)